Title | Type | SJR | H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | %Female (2014) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacology and Therapeutics | journal | 4.048 Q1 | 233 | 107 | 314 | 21251 | 3282 | 313 | 11.04 | 198.61 | 37.95 | |
2 | Drug Metabolism Reviews | journal | 1.633 Q1 | 108 | 30 | 89 | 4924 | 501 | 85 | 5.51 | 164.13 | 45.19 | |
3 | Perspectives in Medicinal Chemistry | journal | 0.108 Q4 | 17 | 5 | 2 | 700 | 0 | 2 | 0.00 | 140.00 | 30.00 | |
4 | Drug Resistance Updates | journal | 3.578 Q1 | 132 | 9 | 63 | 904 | 687 | 59 | 10.06 | 100.44 | 34.21 | |
5 | Expert Opinion on Emerging Drugs | journal | 0.982 Q2 | 54 | 41 | 129 | 3944 | 391 | 126 | 3.18 | 96.20 | 35.20 | |
6 | Neurotherapeutics | journal | 2.433 Q1 | 136 | 79 | 206 | 7345 | 1133 | 193 | 5.41 | 92.97 | 40.59 | |
7 | Expert Review of Neurotherapeutics | journal | 1.069 Q1 | 98 | 147 | 476 | 13542 | 1421 | 438 | 2.85 | 92.12 | 32.02 | |
8 | CNS Drugs | journal | 1.922 Q1 | 129 | 95 | 255 | 8727 | 1477 | 236 | 5.79 | 91.86 | 40.23 | |
9 | Side Effects of Drugs Annual | book series | 0.101 Q4 | 9 | 108 | 105 | 9908 | 3 | 6 | 0.04 | 91.74 | 0.00 | |
10 | Vaccines | journal | 0.123 Q4 | 85 | 42 | 2 | 3639 | 0 | 1 | 0.00 | 86.64 | 45.03 | |
11 | Expert Opinion on Investigational Drugs | journal | 1.431 Q1 | 117 | 140 | 442 | 11529 | 1741 | 434 | 4.18 | 82.35 | 39.36 | |
12 | Frontiers in Pharmacology | journal | 1.560 Q1 | 154 | 272 | 444 | 20945 | 1872 | 425 | 4.14 | 77.00 | 41.61 | |
13 | Paediatric Drugs | journal | 0.777 Q2 | 70 | 49 | 134 | 3691 | 320 | 127 | 2.43 | 75.33 | 45.71 | |
14 | Cochrane Database of Systematic Reviews | journal | 2.841 Q1 | 327 | 1583 | 3520 | 111925 | 20788 | 3454 | 5.35 | 70.70 | 46.15 | |
15 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 1.142 Q1 | 47 | 40 | 55 | 2804 | 208 | 54 | 3.57 | 70.10 | 42.38 | |
16 | Expert Review of Anticancer Therapy | journal | 0.850 Q2 | 85 | 159 | 521 | 11084 | 1112 | 491 | 2.30 | 69.71 | 31.62 | |
17 | Expert Opinion on Pharmacotherapy | journal | 0.764 Q2 | 93 | 243 | 750 | 16898 | 2033 | 718 | 2.91 | 69.54 | 32.40 | |
18 | Biologics: Targets and Therapy | journal | 1.096 Q1 | 47 | 22 | 80 | 1520 | 329 | 78 | 4.22 | 69.09 | 33.33 | |
19 | Expert Review of Clinical Pharmacology | journal | 0.870 Q2 | 60 | 100 | 218 | 6825 | 535 | 185 | 2.18 | 68.25 | 38.21 | |
20 | Clinical Pharmacokinetics | journal | 1.928 Q1 | 184 | 83 | 195 | 5545 | 1171 | 189 | 5.73 | 66.81 | 38.58 | |
21 | Expert Opinion on Drug Safety | journal | 0.992 Q2 | 90 | 165 | 262 | 10875 | 873 | 256 | 3.44 | 65.91 | 46.21 | |
22 | Journal of International Peacekeeping | journal | 0.210 Q3 | 14 | 16 | 49 | 1045 | 36 | 49 | 0.50 | 65.31 | 30.00 | |
23 | Expert Opinion on Orphan Drugs | journal | 0.191 Q3 | 27 | 130 | 100 | 8468 | 52 | 100 | 0.52 | 65.14 | 43.41 | |
24 | Adverse Drug Reaction Bulletin | journal | 0.101 Q4 | 8 | 5 | 18 | 321 | 1 | 18 | 0.08 | 64.20 | 30.00 | |
25 | Current Cardiovascular Risk Reports | journal | 0.329 Q3 | 34 | 55 | 226 | 3524 | 151 | 224 | 0.62 | 64.07 | 33.12 | |
26 | American Journal of Cardiovascular Drugs | journal | 0.992 Q2 | 60 | 40 | 133 | 2536 | 350 | 123 | 2.60 | 63.40 | 32.17 | |
27 | Drugs | journal | 1.672 Q1 | 188 | 155 | 446 | 9793 | 2430 | 439 | 5.39 | 63.18 | 35.00 | |
28 | Antibiotics | journal | 0.365 Q3 | 77 | 41 | 37 | 2586 | 55 | 36 | 1.49 | 63.07 | 38.07 | |
29 | Therapeutic Advances in Infectious Disease | journal | 0.209 Q3 | 29 | 10 | 14 | 629 | 11 | 13 | 0.79 | 62.90 | 42.86 | |
30 | Infection and Drug Resistance | journal | 0.777 Q2 | 65 | 35 | 71 | 2165 | 171 | 70 | 2.28 | 61.86 | 35.38 | |
31 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.061 Q1 | 57 | 56 | 168 | 3331 | 457 | 163 | 2.55 | 59.48 | 30.08 | |
32 | BioDrugs | journal | 0.875 Q2 | 79 | 48 | 146 | 2839 | 412 | 144 | 3.40 | 59.15 | 35.84 | |
33 | Open Access Journal of Clinical Trials | journal | 0.201 Q3 | 15 | 7 | 42 | 411 | 21 | 38 | 0.53 | 58.71 | 60.71 | |
34 | Journal of Psychopharmacology | journal | 1.659 Q1 | 135 | 134 | 471 | 7855 | 1966 | 446 | 4.35 | 58.62 | 36.41 | |
35 | Drugs and Aging | journal | 1.330 Q1 | 109 | 87 | 284 | 5042 | 998 | 264 | 3.58 | 57.95 | 41.41 | |
36 | Inflammopharmacology | journal | 1.056 Q1 | 68 | 36 | 113 | 2031 | 396 | 108 | 3.82 | 56.42 | 38.84 | |
37 | Therapeutic Advances in Drug Safety | journal | 0.360 Q3 | 46 | 21 | 70 | 1183 | 78 | 66 | 1.06 | 56.33 | 30.77 | |
38 | European Neuropsychopharmacology | journal | 2.209 Q1 | 130 | 192 | 403 | 10696 | 2152 | 382 | 4.43 | 55.71 | 40.93 | |
39 | International Journal of Neuropsychopharmacology | journal | 1.924 Q1 | 125 | 219 | 445 | 12164 | 2061 | 433 | 4.27 | 55.54 | 39.37 | |
40 | Journal of Cardiovascular Development and Disease | journal | 32 | 19 | 0 | 1042 | 0 | 0 | 0.00 | 54.84 | 36.11 | ||
41 | AIDS Reviews | journal | 1.764 Q1 | 62 | 38 | 90 | 2075 | 301 | 67 | 3.53 | 54.61 | 37.50 | |
42 | Clinical Practice | journal | 0.126 Q4 | 10 | 82 | 148 | 4462 | 25 | 124 | 0.17 | 54.41 | 36.52 | |
43 | European Archives of Psychiatry and Clinical Neuroscience | journal | 1.415 Q1 | 111 | 84 | 280 | 4506 | 905 | 247 | 3.24 | 53.64 | 38.19 | |
44 | Synergy | journal | 15 | 18 | 0 | 947 | 0 | 0 | 0.00 | 52.61 | 38.00 | ||
45 | Pulmonary Pharmacology and Therapeutics | journal | 1.108 Q1 | 81 | 87 | 276 | 4576 | 887 | 257 | 3.34 | 52.60 | 38.40 | |
46 | Clinical Pharmacology: Advances and Applications | journal | 0.844 Q2 | 34 | 19 | 46 | 987 | 128 | 41 | 2.72 | 51.95 | 29.58 | |
47 | Journal of Psychiatry and Neuroscience | journal | 2.872 Q1 | 114 | 54 | 148 | 2797 | 760 | 119 | 4.56 | 51.80 | 33.11 | |
48 | Experimental and Clinical Psychopharmacology | journal | 1.477 Q1 | 101 | 61 | 155 | 3142 | 501 | 153 | 3.05 | 51.51 | 41.05 | |
49 | Psychopharm Review | trade journal | 0.111 Q4 | 5 | 2 | 36 | 103 | 7 | 36 | 0.17 | 51.50 | 20.00 | |
50 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.783 Q2 | 61 | 89 | 248 | 4509 | 532 | 233 | 1.97 | 50.66 | 37.50 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®